Solid lipid nanoparticles of irbesartan: preparation, characterization, optimization and pharmacokinetic studies
ABSTRACT Irbesartan is an antihypertensive with limited bioavailability and solid lipid nanoparticles (SLN) is one of the approaches to improve bioavailability. Solid lipid nanoparticles were prepared using glyceryl monostearate by solvent emulsification method followed by probe sonication. Irbesart...
Main Authors: | Deepthi Soma, Zenab Attari, Meka Sreenivasa Reddy, Atmakuri Damodaram, Kunnatur Balasundara Gupta Koteshwara |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidade de São Paulo
2017-04-01
|
Series: | Brazilian Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502017000100602&lng=en&tlng=en |
Similar Items
-
Pharmacokinetic interaction between irbesartan and Orthosiphon stamineus extract in rat plasma
by: Nur Meilis, et al.
Published: (2016-02-01) -
Comparative bioavailability of a newly developed Irbesartan 300 mg containing preparation
by: Petrov Andrey D., et al.
Published: (2018-01-01) -
Observational study on patients’ compliance with Irbesartan in essential hypertension “I Comply”
by: K. Leon, et al.
Published: (2014-03-01) -
Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients withtype 2 diabetes mellitus and mild hypertension:a sequential, randomized, double-blind clinical trial
by: - Giuseppe Derosa, et al.
Published: (2009-03-01) -
Simultaneous Analysis of Irbesartan and Hydrochlorothiazide: An Improved HPLC Method with the Aid of a Chemometric Protocol
by: Predrag Stankovic, et al.
Published: (2012-03-01)